Paul Talmo - 20 Feb 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Technology Officer
Signature
/s/ Megan Smeykal, Attorney-in-Fact
Issuer symbol
TELA
Transactions as of
20 Feb 2026
Net transactions value
-$5,539
Form type
4
Filing time
24 Feb 2026, 20:00:18 UTC
Previous filing
02 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Talmo Paul Chief Technology Officer C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN /s/ Megan Smeykal, Attorney-in-Fact 24 Feb 2026 0001899089

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +57,000 +46% $0.000000 180,882 20 Feb 2026 Direct F1
transaction TELA Common Stock Tax liability $2,428 -3,385 -1.9% $0.7174 177,497 21 Feb 2026 Direct F2
transaction TELA Common Stock Tax liability $3,111 -4,061 -2.3% $0.7660 173,436 23 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +85,000 $0.000000 85,000 20 Feb 2026 Common Stock 85,000 $0.7170 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3 The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.